UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.e1843-e1849

2022

Volltextzugriff (PDF)

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Oncogene, 2016-05, Vol.35 (21), p.2687-2697

2016

Volltextzugriff (PDF)

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

Oncogene, 2010-10, Vol.29 (42), p.5724-5728

2010

Volltextzugriff (PDF)

678P Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2021-09, Vol.32, p.S699-S700

2021

Volltextzugriff (PDF)

Familial Risk Of Kidney Cancer

Annals of epidemiology, 2008-09, Vol.18 (9), p.716-716

2008

Volltextzugriff (PDF)

Nnkoac Sensitivity As A Predictive Marker For Renal Cancer In Never- And Former- Smokers

Annals of epidemiology, 2008-09, Vol.18 (9), p.716-716

2008

Volltextzugriff (PDF)

A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2019-10, Vol.30, p.v389-v390

2019

Volltextzugriff (PDF)

963P - A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2019-10, Vol.30, p.v389-v390

2019

Volltextzugriff (PDF)

Interim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2017-09, Vol.28, p.v404-v404

2017

Volltextzugriff (PDF)

Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: A joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration

Annals of oncology, 2017-09, Vol.28, p.v304-v305

2017

Volltextzugriff (PDF)

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

Annals of oncology, 2011-05, Vol.22 (5), p.1048-1053

2011

Volltextzugriff (PDF)

1042 Predictors of occult lymph node metastases in patients with locally advanced renal cell carcinoma: Who should have a lymph node dissection?

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e1042-e1042

2014

Volltextzugriff (PDF)

Re: Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses

Journal of urological surgery, 2018-03, Vol.5 (1), p.57-57

2018

Volltextzugriff (PDF)

Reply to Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies?

Annals of oncology, 2011-05, Vol.22 (5), p.1243-1243

2011

Volltextzugriff (PDF)

Clinical Application of Positron Emission Tomography (PET) in Designing Radiation Fields in Non-Small Cell Lung Cancer (NSCLC) Patients

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S101-S102

2005

Volltextzugriff (PDF)

Loss of type III transforming growth factor-[beta] receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma

Oncogene, 2010-05, Vol.29 (20), p.2905

2010

Volltextzugriff (PDF)

PD-08.01

Urology (Ridgewood, N.J.), 2006-11, Vol.68, p.28

2006

Volltextzugriff (PDF)

The influence of race on the attitudes of radiation oncology patients towards clinical trial enrollment

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S141-S142

2004

Volltextzugriff (PDF)

PD-08.01: Partial nephrectomy is safe and efficacious for pathologic stage T2-T3b renal cell carcinoma

Urology (Ridgewood, N.J.), 2006, Vol.68, p.28-28

2006

Volltextzugriff (PDF)

762 RADIOFREQUENCY ABLATION (RFA) OF RENAL TUMORS: CLINICAL, RADIOGRAPHIC, AND PATHOLOGIC RESULTS FROM A TERTIARY CANCER CENTRE

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.246-246

2010

Volltextzugriff (PDF)

Percutaneous Radiofrequency Ablation of Renal Tumors: Technique, Complications and Outcomes

The Journal of urology, 2006-05, Vol.175 (5), p.1650-1650

2006

Volltextzugriff (PDF)

A MULTICENTRE, RANDOMISED, PHASE 3 TRIAL OF A NOVEL, AUTOLOGOUS, THERAPEUTIC VACCINE (VITESPEN) VS. OBSERVATION AS ADJUVANT THERAPY IN PATIENTS AT HIGH RISK OF RECURRENCE AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2008, Vol.7 (3), p.244-244

2008

Volltextzugriff (PDF)

misexpression screen reveals effects of bag-of-marbles and TGFbeta class signaling on the Drosophila male germ-line stem cell lineage

Genetics (Austin), 2004, Vol.167 (2), p.707-723

2004

Volltextzugriff (PDF)

118 REMOVAL OF AT LEAST 8 NODES IMPROVES BOTH STAGING AND OUTCOMES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.150-150

2009

Volltextzugriff (PDF)

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

The Journal of urology, 2006-02, Vol.175 (2), p.481-482

2006

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(145)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(60)
Physical Sciences
(34)
Humans
(29)
Physics
(27)
Animals
(24)
Female
(23)
Male
(21)
Technology
(19)
Astronomy & Astrophysics
(16)
Biological And Medical Sciences
(16)
Veterinary Sciences
(15)
Astrophysics
(14)
Engineering
(13)
Physics, Applied
(11)
Astronomy And Astrophysics
(10)
Engineering, Electrical & Electronic
(10)
Medical Sciences
(10)
Exact Sciences And Technology
(9)
Platelet Function Tests - Veterinary
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

678P Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI)

Familial Risk Of Kidney Cancer

Nnkoac Sensitivity As A Predictive Marker For Renal Cancer In Never- And Former- Smokers

A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)

963P - A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)

Interim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: A joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

1042 Predictors of occult lymph node metastases in patients with locally advanced renal cell carcinoma: Who should have a lymph node dissection?

Re: Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses

Reply to Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies?

Clinical Application of Positron Emission Tomography (PET) in Designing Radiation Fields in Non-Small Cell Lung Cancer (NSCLC) Patients

Loss of type III transforming growth factor-[beta] receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma

PD-08.01

The influence of race on the attitudes of radiation oncology patients towards clinical trial enrollment

PD-08.01: Partial nephrectomy is safe and efficacious for pathologic stage T2-T3b renal cell carcinoma

762 RADIOFREQUENCY ABLATION (RFA) OF RENAL TUMORS: CLINICAL, RADIOGRAPHIC, AND PATHOLOGIC RESULTS FROM A TERTIARY CANCER CENTRE

Percutaneous Radiofrequency Ablation of Renal Tumors: Technique, Complications and Outcomes

A MULTICENTRE, RANDOMISED, PHASE 3 TRIAL OF A NOVEL, AUTOLOGOUS, THERAPEUTIC VACCINE (VITESPEN) VS. OBSERVATION AS ADJUVANT THERAPY IN PATIENTS AT HIGH RISK OF RECURRENCE AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA

misexpression screen reveals effects of bag-of-marbles and TGFbeta class signaling on the Drosophila male germ-line stem cell lineage

118 REMOVAL OF AT LEAST 8 NODES IMPROVES BOTH STAGING AND OUTCOMES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

Suchergebnisse filtern